Production (Stage)
D
Arcutis Biotherapeutics, Inc. ARQT
$13.98 $0.322.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 29.17% 83.72% 7.21% 26.28% 55.83%
Total Depreciation and Amortization 774.86% 18.96% 270.03% -9.07% -1.38%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 4.20% 20.61% -3.69% 13.03% 5.52%
Change in Net Operating Assets -225.01% -481.27% 58.56% 25.48% 39.57%
Cash from Operations 3.87% 98.67% 21.13% 32.14% 60.67%
Capital Expenditure -- 100.00% -123.44% -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 143.06% 156.09% 86.17% -169.51% -126.61%
Cash from Investing 140.95% 156.08% 86.12% -169.72% -126.63%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.76% -97.39% -54.56% 36.36% 161,664.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -99.76% -198.11% -54.56% 36.36% 161,664.00%
Foreign Exchange rate Adjustments 105.48% -444.12% 230.67% -388.89% -40.38%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -117.98% -233.02% 2,045.99% -546.36% 269.30%